Shares of Clorox Company (The) (NYSE:CLX) have been assigned a consensus rating of “Hold” from the fourteen brokerages that are currently covering the stock, Marketbeat.com reports. Three investment analysts have rated the stock with a sell recommendation, nine have given a hold recommendation and two have given a buy recommendation to the company. The average 12-month price objective among brokerages that have covered the stock in the last year is $125.42.
Several research firms recently issued reports on CLX. Jefferies Group LLC reaffirmed a “hold” rating and issued a $137.00 price objective (up from $136.00) on shares of Clorox Company (The) in a research report on Wednesday, August 9th. BidaskClub raised Clorox Company (The) from a “strong sell” rating to a “sell” rating in a research report on Monday, July 31st. Barclays PLC reaffirmed an “equal weight” rating and issued a $136.00 price objective (down from $140.00) on shares of Clorox Company (The) in a research report on Friday, August 4th. BMO Capital Markets set a $150.00 target price on shares of Clorox Company (The) and gave the company a “buy” rating in a research note on Thursday, August 3rd. Finally, Royal Bank Of Canada reiterated a “hold” rating and set a $115.00 target price on shares of Clorox Company (The) in a research note on Wednesday, August 2nd.
TRADEMARK VIOLATION WARNING: “Clorox Company (The) (CLX) Receives Average Recommendation of “Hold” from Brokerages” was first reported by Community Financial News and is the property of of Community Financial News. If you are accessing this piece on another website, it was illegally copied and reposted in violation of United States & international copyright & trademark law. The original version of this piece can be accessed at https://www.com-unik.info/2017/10/31/clorox-company-the-clx-receives-average-recommendation-of-hold-from-brokerages.html.
In other news, COO Dawn C. Willoughby sold 2,158 shares of the company’s stock in a transaction that occurred on Tuesday, August 29th. The shares were sold at an average price of $138.00, for a total value of $297,804.00. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, EVP James E. Foster sold 9,861 shares of the company’s stock in a transaction that occurred on Wednesday, August 23rd. The stock was sold at an average price of $138.51, for a total transaction of $1,365,847.11. Following the completion of the transaction, the executive vice president now owns 22,069 shares in the company, valued at $3,056,777.19. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 21,242 shares of company stock valued at $2,944,449. 1.00% of the stock is owned by corporate insiders.
Several hedge funds have recently modified their holdings of CLX. Dynamic Technology Lab Private Ltd purchased a new stake in shares of Clorox Company (The) in the 1st quarter valued at approximately $313,000. Tredje AP fonden grew its position in shares of Clorox Company (The) by 29.3% in the 1st quarter. Tredje AP fonden now owns 37,476 shares of the company’s stock valued at $5,053,000 after buying an additional 8,496 shares during the last quarter. AE Wealth Management LLC purchased a new position in shares of Clorox Company (The) in the 1st quarter valued at $385,000. ARGI Investment Services LLC grew its position in shares of Clorox Company (The) by 23.7% in the 1st quarter. ARGI Investment Services LLC now owns 7,714 shares of the company’s stock valued at $1,040,000 after buying an additional 1,480 shares during the last quarter. Finally, Choate Investment Advisors grew its position in shares of Clorox Company (The) by 32.7% in the 1st quarter. Choate Investment Advisors now owns 3,285 shares of the company’s stock valued at $443,000 after buying an additional 810 shares during the last quarter. Hedge funds and other institutional investors own 71.56% of the company’s stock.
Clorox Company (NYSE CLX) traded up 0.97% on Thursday, hitting $126.53. The stock had a trading volume of 2,163,610 shares. Clorox Company has a 1-year low of $111.24 and a 1-year high of $141.76. The company has a market cap of $16.33 billion, a P/E ratio of 23.72 and a beta of 0.40. The stock has a 50 day moving average price of $130.93 and a 200 day moving average price of $133.87.
Clorox Company (The) (NYSE:CLX) last released its quarterly earnings data on Thursday, August 3rd. The company reported $1.53 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.49 by $0.04. The business had revenue of $1.65 billion for the quarter, compared to analysts’ expectations of $1.65 billion. Clorox Company (The) had a return on equity of 190.67% and a net margin of 11.74%. The firm’s quarterly revenue was up 2.9% on a year-over-year basis. During the same period in the prior year, the firm posted $1.30 EPS. On average, equities research analysts expect that Clorox Company will post $5.64 EPS for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which will be paid on Monday, November 13th. Investors of record on Wednesday, October 25th will be paid a dividend of $0.84 per share. The ex-dividend date is Tuesday, October 24th. This represents a $3.36 annualized dividend and a yield of 2.66%. Clorox Company (The)’s dividend payout ratio is presently 63.04%.
Clorox Company (The) Company Profile
The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.
What are top analysts saying about Clorox Company (The)? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Clorox Company (The) and related companies.